The treatment is an emulsion of dodecafluoropentane that helps transfer oxygen into the tumor when administered intravenously, according to a June 26 system news release.
The increased oxygen delivery to hypoxic glioblastoma tissue could boost the effectiveness of radiation and chemotherapy, according to the release.